News

Activation Capital $15,000 Pitch Contest in November to Shine Light on Virginia Businesses

The inaugural Pitch Virginia event, powered by Activation Capital, will take place on Wednesday, November 10 at the newly opened Shift Retail Lab at VCU, an initiative of the VCU da Vinci Center.  Kicking off with a design thinking workshop in the morning, the day will be filled with pitches from high growth, main street and student companies competing for $15,000 of prize money, concluding with the grand opening event of the Shift Retail Lab at VCU with a cocktail networking event and open house tours of the space in the evening.  These events are an official activity of Global Entrepreneurship Week, an international movement to empower entrepreneurs and help make it possible for anyone, anywhere to start and scale.

Pitch Virginia is an opportunity to highlight the entrepreneurs and startup companies in the Commonwealth.  The contest will feature three categories: high growth startups, main street companies, and student-owned ventures.  Capital One is sponsoring the event and donated $15,000 in cash prizes for winning companies.

Matt Briggs, VP of Capital One Card Technology and Platforms shared, “Capital One is committed to elevating the mission driven small business ecosystem in Virginia and our support for this event allows us to empower entrepreneurs at all levels – student entrepreneurs, brick and mortar businesses, and high growth startups with the potential to scale. We are looking forward to November and Pitch Virginia to bring innovative minds and ecosystem supporters together to continue developing Virginia’s small business sector.”

Speaking about Pitch Virginia, Chandra Briggman, President and CEO of Activation Capital said, “We wanted to create a new event that will cater to founders and entrepreneurs, showcasing all types of companies, and feel Pitch Virginia will be a place for people to come together for networking and community, while also supporting the entrepreneurial ecosystem in the Commonwealth.”

Companies can apply to pitch and individuals can register to attend at http://activation.capital/pitch.

Recent News

03/12/2026

Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to QRX003 lotion (4%) for the treatment of Netherton Syndrome, a rare

03/11/2026

ATCC Secures NIAID Contract to Strengthen U.S. Preparedness Against Emerging Infectious Diseases

ATCC has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract (number 75N93025D00017) with an ordering period of 7 years with Federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), an institute within the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS). The contract, with an initial

03/10/2026

ivWatch and Aon Address Costly and Underreported Patient Harm Epidemic with New Return on Investment Model

ivWatch, the IV safety company, has partnered with Aon, a leading global insurance broker and risk consultant, to quantify the clinical and financial impact of severe IV infiltration and extravasation injuries – one of the most underreported and costly adverse events in healthcare – and to model the return on investment associated with detecting these